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Neurosecretory protein GL (NPGL) and neurosecretory protein GM (NPGM) are paralogs recently dis-
covered in birds and in mammals. The post-translational products of NPGL and of NPGM genes
include a signal peptide sequence, a glycine amidation signal, and a dibasic amino acid cleavage site.
This suggests that the mature forms of NPGL and of NPGM are small proteins secreted in the
hypothalamus and containing an amidated C-terminus. However, endogenous NPGL and NPGM have
not yet been identified. Chicken NPGL and NPGM have two highly conserved Cys residues that are
likely to form a disulfide bond, while mammalian NPGM has one additional Cys residue located
between the two conserved Cys residues and the correct disulfide bond pattern is unclear. In this
study, we prepared rat NPGM to elucidate the structure of its mature form. We first expressed the
predicted mature NPGM, containing an extra C-terminal Gly, in Escherichia coli SHuffle cells, which
are engineered to promote the formation of native disulfide bridges in recombinant proteins. We
observed the presence of a disulfide bond between the N-terminal Cys residue and the second Cys
residue, while the C-terminal Cys residue was free. Secondly, we transfected a construct containing
the entire NPGM open reading frame into Chinese Hamster Ovary cells, and observed that NPGMwas
cleaved immediately after the signal peptide and that it was secreted into the medium.
Furthermore, the protein presented a disulfide bond at the same location observed in recombinant
NPGM.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Using a cDNA subtraction screen, we recently identified a novel
cDNA highly expressed in the chicken hypothalamus [1]. A genome
database search revealed the existence of a paralog gene; both are
widely conserved in vertebrates [1]. The predicted post-
translational products of the two genes from chicken, human,
and rat are shown schematically in Fig. 1A. Each precursor protein
includes a signal peptide at the N-terminus, a glycine amidation
signal, and a dibasic amino acid cleavage site. This architecture
suggests that a small 80–88 amino acid protein containing an ami-
dated C-terminus is secreted as a mature form. The predicted
mature proteins have characteristic C-terminal sequences, Gly-
Leu-NH2 or Gly-Met-NH2, which suggested their name: neurose-
cretory protein GL (NPGL) and neurosecretory protein GM (NPGM),respectively [1]. In chicks, subcutaneous infusions of rat NPGL,
which shares 83% identity with chicken NPGL, caused an increase
of the body weight without affecting food intake [1]. The function
of NPGM is still unknown.
NPGL and NPGM have highly conserved Cys residues that likely
form an intramolecular disulfide bond. Disulfide bonds are impor-
tant for the biological activity and for the stability of a protein [2].
For example, insulin has one intra-molecular and two inter-
molecular disulfide bonds that stabilize its secondary structure
and contribute to its overall hydrophobicity; when any one of
these bonds is lost, the receptor binding activity decrease below
0.02% [3]. It is noteworthy that the number of Cys residues in
mammalian NPGL and NPGM are different. NPGL contains two
Cys residues, which likely form a disulfide bond. On the other hand,
mammalian NPGM has two Cys residues at the conserved positions
and one additional Cys residue, namely Cys1, Cys2, and Cys3
(Fig. 1A). These three Cys residues can potentially give rise to three
different disulfide bonds, Cys1–Cys2, Cys1–Cys3, or Cys2–Cys3; from
NPGM primary structure is however impossible to claim which one
will form in the native protein.
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Fig. 1. Primary structure of NPGL and NPGM precursor proteins. (A) Schematic alignment of NPGL and NPGM precursor proteins derived from chicken, human, and rat
genomic DNA sequences. The amino acid sequences include a signal peptide (SP), two or three Cys residues (C), sequences characteristic of each species (GL or GM), a C-
terminal amidation signal and a dibasic processing site (GKR or GRR). The predicted mature peptide regions are painted gray and their amino acid lengths are indicated. The
positions of the conserved Cys residues, named Cys1 to Cys3 for descriptive purpose, are indicated by dash line. (B) Amino acid sequence of rat NPGM precursor protein. The
signal peptide and the mature NPGM are underlined with a dash line and a solid line, respectively. The C-terminal amidation signal and the dibasic processing site are
underlined with a double line. The three Cys residues are highlighted in bold.
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tion of the disulfide bond, we produced rat NPGM in Escherichia coli
(E. coli) and in Chinese Hamster Ovary (CHO) cells. The amino acid
sequence of the precursor protein of rat NPGM is shown in Fig. 1B.
First, we expressed the predicted mature NPGM in E. coli and we
determined the location of the disulfide bond in the recombinant
protein using protease digestion. Recombinant NPGM was also
used as an antigen for raising specific antibody. Secondly, a con-
struct containing the entire NPGM open reading frame was trans-
fected into CHO cells to determine whether NPGM was secreted
into the culture medium. Finally, the structure of the secreted
NPGM and the location of the disulfide bond were analyzed.
2. Materials and methods
2.1. RNA and cDNA preparation
Male Wistar rats (7 weeks old) were purchased from a commer-
cial company (Kyudo, Saga, Japan), housed on a 12:12 light–dark
cycle in a room maintained at 23 ± 2 C with ad libitum access to
food and tap water. All animal procedures were performed accord-
ing to the Guide for the Care and Use of Laboratory Animals pre-
pared by Hiroshima University (Higashi-Hiroshima, Japan).
Rats were sacrificed by decapitation. The medial basal hypotha-
lamus was dissected and snap-frozen in liquid nitrogen for further
RNA processing. Total RNA was extracted from the medial basal
hypothalamus using the TRIzol reagent (Life technologies, Carls-
bad, CA, USA) followed by the isolation of poly(A)+ RNA with
Oligotex-(dT) 30 (Takara Bio, Shiga, Japan). The first-strand of
cDNA was synthesized from the mRNA using a ReverTra Ace qPCR
RT Kit (TOYOBO, Osaka, Japan).
2.2. Construction of the NPGM-Gly expression plasmid
The cDNA encoding NPGM was amplified with a forward
primer (50- GCCGCATATGGACTTGGAATTTCAGAAAGG -30) contain-ing the Nde I site (underlined) and a reverse primer
containing the EcoR I site (underlined), stop codon (bold), and the
codon encoding the amidating donor residue, Gly (squared). PCR
amplifications were carried out with the Ex Taq polymerase
(Takara Bio) using the following program: 95 C for 20 s, 40 cycles
at 95 C for 20 s, at 55 C for 20 s, and at 72 C for 20 s. Additional
elongation was performed at 72 C for 10 min for TA cloning. The
insert was ligated into the pGEM-T easy vector (Promega, Madison,
WI, USA) using Ligation high (TOYOBO), to produce pGEM-NPGM-
Gly plasmid. E. coli DH5a cells (Nippon Gene, Tokyo, Japan) were
transformed with the plasmid and grown overnight at 37 C on
an LB agar plate containing 50 lg/ml of ampicillin. The colonies
were then grown in fresh LB medium containing ampicillin at
37 C overnight. The amplified plasmids were extracted using
NucleoSpin Plasmid (MACHEREY–NAGEL, Düren, Germany).
The pGEM-NPGM-Gly plasmid and pCold TF DNA vector (Takara
Bio) were digested separately with Nde I and EcoR I, and ligated
using Ligation high (TOYOBO) to produce pCold-NPGM-Gly plas-
mid. The plasmid was propagated as described above. The
sequence of the insert was confirmed using ABI Prism 310 Genetic
Analyzer (Applied Biosystems, Carlsbad, CA, USA).
2.3. Expression of recombinant His6-TF tagged NPGM-Gly
The pCold-NPGM-Gly plasmid was transformed into E. coli BL21
strain (GE Healthcare, Little Chalfont, UK) or E. coli SHuffle strain
(New England Biolabs, Ipswich, MA, USA). The transformants were
selected on LB agar plates containing 50 lg/ml of ampicillin and
grown at 37 C overnight. The colonies were then grown in LB
medium containing ampicillin at 37 C overnight. An aliquot of
the pre-culture solution was diluted with 200 ml of fresh LB med-
ium and incubated at 37 C. When the cells reached an optical den-
sity (OD)600 of 0.5, the culture was refrigerated at 15 C for 30 min.
The culture solution was added with isopropyl b-D-1-
thiogalactopyranoside (IPTG) at a final concentration of 0.1 mM
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by centrifugation and frozen at 80 C until further use.
The expression of the target protein in soluble and in insoluble
fractions was confirmed by SDS–PAGE. An aliquot of the cell pellet
was lysed with BugBuster Protein Extraction Reagent (Novagen,
Madison, WI, USA) and separated by centrifugation. Each sample
was dissolved in SDS sample buffer and subjected to 15% SDS–
PAGE. The gels were stained with 2D-SILVER STAIN II (Cosmobio,
Tokyo, Japan).
2.4. Affinity purification and tag removal
The cell pellet was fully resuspended with BugBuster Protein
Extraction Reagent (Novagen) and centrifuged. The supernatant
was purified by Ni–NTA agarose (Qiagen, Venlo, Netherlands).
The His6-TF-NPGM-Gly protein was allowed to bind to the resin
for 1 h at 4 C before elution with the elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 100 mM imidazole, pH 8.0).
The elution solution was dialyzed at 4 C overnight in a Factor
Xa reaction buffer (20 mM Tris–HCl, 100 mM NaCl, 2 mM CaCl2,
pH 8.0). The protein solution was further added with 2 lg of Factor
Xa protease (New England Biolabs) per 1 mg of protein,
and incubated at 20 C for 16 h. The digestion reaction was stopped
with 1 mM phenylmethylsulfonyl fluoride (PMSF). The cleaved
His6-TF-tag was removed by centrifugation after adding acetone
at a final concentration of 40%. The supernatant was purified by
reverse-phase high-performance liquid chromatography (RP-HPLC)
using the TSKgel CN-80Ts column (4.6 250mm; Tosoh, Tokyo,
Japan) with a linear gradient of 35–55% acetonitrile (CH3CN)
containing 0.1% TFA over 40 min with a flow rate of 0.5 ml/min.
The elution was monitored at 220 nm. The collected peak was evap-
orated and lyophilized. The mass value was analyzed by electro-
spray ionization mass spectrometry (ESI-MS) on the LTQ Orbitrap
XL and Xcalibur (Thermo Fisher Scientific, Waltham, MA, USA).
2.5. Analysis of disulfide bond of NPGM-Gly expressed in E. coli
0.1 mg of NPGM-Gly was dissolved in 500 ll of a buffer (50 mM
iodoacetamide, 50 mM sodium phosphate, pH 7.0) and incubated
at room temperature for 2 h under the quenching condition. The
alkylated NPGM-Gly was purified by RP-HPLC using a C8 column
(10  150 mm; YMC, Kyoto, Japan) with a linear gradient of 40–
60% CH3CN containing 0.1% TFA over 40 min with a flow rate of
0.5 ml/min. The elution was monitored at 220 nm. The collected
peak was evaporated.
Non-alkylated or alkylated NPGM-Gly was dissolved in 200 ll
of 50 mM sodium phosphate buffer (pH 7.0) containing 0.5 lg of
endoproteinase Asp-N (Roche Diagnostics, Basel, Switzerland)
and incubated at 37 C overnight. The mixture was purified simi-
larly by RP-HPLC with a linear gradient of 10–60% CH3CN contain-
ing 0.1% TFA over 50 min. The collected peaks were analyzed by
ESI-MS.
2.6. C-terminal amidation of recombinant NPGM-Gly
Amidation of NPGM-Gly was performed using peptidylglycine
a-amidating enzyme (R&D systems, Minneapolis, MN, USA) as pre-
viously published [4]. 1 mg of NPGM-Gly was dissolved in 2 ml of
buffer (0.2 M Tris–HCl, pH 7.0, 0.5% Nonidet P-40, 5 mM ascorbic
acid, 20 lM CuSO4, 0.1 mg/ml catalase, 2 lg/ml enzyme) and incu-
bated at 37 C overnight. The mixture was purified by RP-HPLC
using a C8 column (4.6  150 mm; YMC) with a linear gradient
of 40–60% CH3CN containing 0.1% TFA over 40 min with a flow rate
of 0.5 ml/min. The elution was monitored at 220 nm. The collected
peaks were analyzed by ESI-MS.2.7. Production of antibody against NPGM
Antisera were raised following our published method [5] using
recombinant NPGM-Gly as antigen. The antigen solution was
mixed with Freund’s complete adjuvant and injected into a rabbit.
After the booster injection, blood was collected and the antibody
purified. The specificity of the antibody was confirmed by dot-
immunoblot analysis. Rat NPGL [6] and NPGM were blotted on a
nitrocellulose membrane and probed with the antibody against
NPGM (1:250 dilution) and revealed with an alkaline
phosphatase-conjugated secondary antibody (1:1000 dilution).
2.8. Establishment of NPGM-expressing CHO cell line
The full-length open reading frame of NPGM was amplified
from cDNA of the medial basal hypothalamus and inserted into
pcDNA3.1 (Life technologies), a mammalian expression vector.
CHO (dehydrofolate reductase; dhfr) cells were transfected with
the NPGM expression vector and dhfr expression vector (pSV2-
dhfr), using X-treme GENE 9 DNA transfection reagent (Roche Diag-
nostics) in 6-well plates. The transfected cells were selected in
nucleoside-free alpha-MEM (Life technologies) containing 10%
fetal bovine serum and 1 mg/ml G418. Gene amplification was
then performed by addition of 5–500 nM methotrexate for
6 weeks.
Expression of NPGM was confirmed by immunocytochemistry.
The cells transfected with a control vector (mock) or with the
NPGM expression vector were re-plated and probed with the anti-
body against NPGM (1:1000 dilution) and incubated with
rhodamine-conjugated goat anti-rabbit IgG (1:1000 dilution).
2.9. Characterization of NPGM expressed by CHO cells
The stably transfected cells were cultured in the serum-free
medium Hyclone CDM4CHO SH30557 (Thermo Fisher Scientific).
400 ml of the culture medium was collected for a week. The
medium was boiled, cooled and, after addition of acetic acid at
final concentration of 5%, centrifuged. The supernatant was frac-
tionated every 2 min by RP-HPLC using a C18 column (TSK gel
ODS-80Ts, 4.6  150 mm; Tosoh) with a linear gradient of 20–
60% CH3CN containing 0.1% TFA over 40 min with a flow rate of
0.5 ml/min. The elution was monitored at 220 nm. Aliquots of
the collected fractions were analyzed by matrix-assisted laser
desorption ionization time-of-flight mass spectrometry (MALDI-
TOF-MS) on the AXIMA-CFR plus (Shimadzu, Kyoto, Japan). The
rest of fractions were evaporated, dissolved in SDS sample buffer,
and subjected to 15% SDS–PAGE. After transfer onto polyvinyli-
dene fluoride membrane (Immobilon-P; MerckMillipore, Darm-
stadt, Germany), the blot was probed with the anti-NPGM
antibody (1:1000 dilution) and incubated with horseradish
peroxidase-conjugated donkey anti-rabbit IgG (GE Healthcare).
The protein bands were detected by ECL Western Blotting Detec-
tion Reagents (Promega).
Fraction 40 was analyzed in more detail. The culture medium
was collected and fractionated by RP-HPLC as described above.
Fraction 40 was dissolved in SDS sample buffer, and subjected
to 15% SDS–PAGE. The gels were stained with Silver Stain MS
kit (Wako Pure Chemical Industries, Osaka, Japan) and the band
running at a similar size to recombinant NPGM-Gly was cut
out. In-gel digestion was performed with trypsin at 35 C over-
night. The digested products were analyzed by MALDI-TOF-MS
and ESI-MS/MS. In a different experiment, fraction 40 was
digested with Asp-N at 37 C overnight. The digested products
were purified by RP-HPLC, and the collected peaks were analyzed
by MALDI-TOF-MS.
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3.1. Expression of NPGM in E. coli
To obtain soluble recombinant NPGM at high purity, we cloned
it into the multiple cloning site of the pCold TF DNA vector. This
plasmid encodes the cold shock inducible cspA promoter, the trans-
lational enhancer element (TEE), which promotes the translation of
the target gene, the poly histidine tag (His6) for affinity purification
of the expressed protein, the bacterial chaperone trigger factor
(TF), which promotes the folding of the nascent peptide chains,
and the cleavage site of Factor Xa protease for removal of His6-TF
tag from the target protein (Fig. 2A). A cDNA encoding the pre-
dicted mature NPGM with an extra Gly residue at the C-terminus
was used for cloning; the Gly serves as an amide donor for the
post-translational in vitro amidation, which is not naturally carried
out by E. coli. E. coli transformed with this expression plasmid pro-
duces His6-TF-NPGM-Gly, with a molecular mass of approximately
62 kDa (His6-TF tag = 52 kDa, NPGM-Gly = 10 kDa). Cleavage of the
His6-TF tag by Factor Xa leaves a His-Met sequence, derived from
the Nde I restriction site, at the N-terminus of NPGM-Gly (Fig. 2A).
Using the above expression vector, we transformed E. coli BL21
strain, which is most widely used, and the E. coli SHuffle strain,
which is modified to assist folding of the expressed proteins and
correct disulfide bonds formation. Most of the His6-TF-NPGM-Gly
precipitated into inclusion bodies when expressed in BL21 strain,
whereas soluble protein was obtained using the SHuffle strain
(Fig. 2B). After expression, His6-TF-NPGM-Gly was purified on a
Ni2+ column, and the His6-TF tag was removed with Factor Xa.
NPGM-Gly was then purified by RP-HPLC to high purity (Fig. 2C).
ESI-MS indicated that the main HPLC peak contained multiple ions
correspondent to the bridged NPGM-Gly species, whose calculated
mass value is 10491.13 [M+H]+ (Fig. 2D). The minor HPLC peak just
after the main peak (Fig. 2C) corresponded to a degradationA 
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RP-HPLC. (D) Purified NPGM-Gly was analyzed by ESI-MS.product of NPGM, which lacked the 5 C-terminal amino acids
due to non-specific digestion by Factor Xa (data not shown). The
yield of NPGM-Gly was 0.4 mg/L.
Specific antibodies against recombinant NPGM-Gly were raised
in rabbit and the specificity was checked by dot-immunoblot anal-
ysis (Fig. 3).
3.2. Analysis of the disulfide bond pattern in recombinant NPGM-Gly
The location of the disulfide bond in recombinant NPGM-Gly
was determined by alkylation of free Cys residue and protease
digestion. The alkylation reaction was performed using iodoac-
etamide. Non-alkylated and alkylated NPGM-Gly were separately
digested using protease Asp-N, which cleaves peptide chains at
the N-terminal side of an aspartic acid residue. Each reaction solu-
tion was purified by RP-HPLC and the collected peaks were
assigned by ESI-MS analysis (Fig. 4A and B). In the digestion of
non-alkylated NPGM-Gly, ‘‘DCLLSRSHGMG” fragment was eluted
at 22 min on RP-HPLC (Fig. 4A). In contrast, in the digestion of alky-
lated NPGM-Gly, the peak of ‘‘DCLLSRSHGMG” fragment disap-
peared and alkylated ‘‘DCLLSRSHGMG” fragment appeared at
21 min on RP-HPCL (Fig. 4A). Bridged ‘‘DLQCWNTCSLTLI” fragment
was obtained in both experiments (Fig. 4A). These results showed
that Cys1 and Cys2 were involved in disulfide bond formation and
Cys3 remained free. Alkylated ‘‘HMDLEFQKGVLAGISPGITA” frag-
ment was also appeared in the digestion of alkylated NPGM-Gly
(Fig. 4A). Some residue was presumably alkylated due to over-
alkylation reaction.
3.3. C-terminal amidation of NPGM-Gly
The C-terminus of recombinant NPGM-Gly was amidated using
an amidating enzyme. The reaction yielded three products, as it
can be seen from the RP-HPLC profile reported in Fig. 5A. Further- GGG ATG GGC TAG GAA TTC -3’  
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MS indicated that peaks 1 and 2 contained a species with mass
value of 10433.16 [M+H]+, corresponding to NPGM-NH2, and
byproducts with mass values of around 10415.15 [M+H]+, corre-
sponding to dehydrated NPGM-NH2 (Fig. 5B). The byproduct from
peak 3 had a mass value of 10465.10 [M+H]+, which is the expected
mass of NPGM-NH2 oxidized in two positions, probably Met-
oxidized product (Fig. 5B).
3.4. Characterization of NPGM secreted from CHO cells
We transfected the plasmid DNA encoding the NPGM precursor
into CHO cells, and confirmed protein expression by immunocyto-
chemistry (Fig. 6A). The cell culture medium was collected and
fractionated every 2 min by RP-HPLC; two intense peaks eluted
in correspondence of fractions 38 and 40 (Fig. 6B). These fractions
were analyzed by western blotting using NPGM-Gly expressed in
E. coli as a positive control (Fig. 6C). Fraction 40 contained a
species that run at a similar size to the one of recombinant
NPGM-Gly, while fraction 38 contained a larger species (Fig. 6C).MALDI-TOF-MS indicated that these species were the C-terminal
26 or 24 amino acid residues-elongated forms of predicted
mature NPGM, respectively.
Further analyses were performed on fraction 40. First, we run a
sample from this fraction on an SDS gel and we digested the
excised band with trypsin, which cleaves peptide chains at the
C-terminal side of lysine or arginine. MALDI-TOF-MS indicated that
the resulting proteolytic products had mass values of 779.39 and
2152.07 [M+H]+, which corresponded to the values calculated for
the ‘‘DLEFQK” and for the ‘‘IEHNVDAFWNFMLFLQK” sequence,
respectively (Fig. 6F). The ‘‘DLEFQK” sequence was confirmed by
ESI-MS/MS (Fig. 6D). Because of the substrate specificity of trypsin,
(Fig. 6F), this result suggests that the ‘‘DLEFQK” region represents
the N-terminus of mature NPGM. In a second experiment, fraction
40 was digested using Asp-N. The two resulting fragments were
analyzed by MALDI-TOF-MS, and were identified as ‘‘DLEFQKGVL
AGISPGITA” and as ‘‘DLQCWNTCSLTLI” (Fig. 6F). In the latter case,
the mass value of 1529.9 [M+Na]+ was corresponded to the
calculated value for a bridged form of the fragment, and this value
was increased of 2 mass units by reduction of the fragment with
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indicates that Cys1 and Cys2 in the fragment form a disulfide
bond.
4. Discussion
While searching for novel neuropeptides and peptide hormone
precursors in the chicken hypothalamus, we found a cDNA encod-
ing a novel small secretory protein, NPGL [1]. We have previously
showed that subcutaneous infusion of NPGL increased body weight
gain in chicks [1]. In addition, we have also discovered the pres-
ence of a paralogous protein in vertebrates, NPGM. In mammals,
NPGM contains three Cys residues and the exact structure of the
endogenous mature form remains unclear, especially regarding
the disulfide bond pattern. In the present study, we characterized
mature NPGM from rat, using E. coli and CHO cells.
In a preliminary experiment, we expressed recombinant NPGM
as a glutathione-S-transferase (GST) fusion protein, using a
conventional E. coli expression system. However, we could only
obtain insoluble protein that precipitated in inclusion bodies. In
the present study, NPGM-Gly was efficiently expressed in soluble
form by cold-shock induction in the E. coli SHuffle strain, using
the cold shock expression vector pCold TF DNA. The vector contains
the trigger factor (TF) fused to the target protein as a solubility tag;
TF is a bacterial chaperone that interacts with nascent proteins and
facilitates their folding [7,8]. The effectiveness of the TF-fusion
approach has been reported in several cases [9,10]. At low induction
temperatures, the expression of target proteins lying downstream
of the cspA promoter is facilitated, whereas expression of most
endogenous proteins is inhibited. This system usually leads to
better results in terms of protein solubility, yield, conformationalA) Confirmation of NPGM expression in CHO cells by immunocytochemistry. Scale
38 (F. 38) and 40 (F. 40) were analyzed by western blot using an antibody agains
was in-gel digested with trypsin. One of the obtained fragments was sequenced by
that one of the fragments had mass value of 1529.9 [M+Na]+ corresponding to the
mple reduction. (F) Trypsin and Asp-N protease digestion sites are indicated by
are indicated by solid or dotted lines. The three Cys residues are highlighted in boldt
.
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NPGM-Gly was insoluble when expressed in E. coli BL21 strain,
while good yields of soluble protein were obtained using E. coli
SHuffle strain. This strain lacks cytoplasmic thioredoxin reductase
(trxB) and glutaredoxin reductase (gor), and contains the cytoplas-
mic disulfide bond isomerase DsbC, which promotes native disul-
fide bonds formation and correct protein folding [12]. We
characterized the pattern of the intramolecular disulfide bond in
recombinant NPGM, as described later in the text.
The presence of a Gly–Arg–Arg sequence in the NPGM precursor
(Fig. 1) suggests that the C-terminus is amidated. We performed
amidation of NPGM-Gly in vitro, since the reaction does not occur
in E. coli. After the amidating enzyme has been isolated from several
animals [13,14], recombinant amidating enzyme has been used for
amidation of various peptides such as mastoparan-X [15], human
adrenomedullin [16], and crustacean hyperglycemic hormone
[4,17,18]. In this study, amidation of the NPGM-Gly C-terminus
resulted in unavoidable side reactions of dehydration and of oxida-
tion, which prevented us from carrying out further investigations,
such as physiological analyses. To improve the yield and purity of
amidated NPGM, we need to use other methods. For example, we
could use the transacylation reaction by carboxypeptidase Y
[19,20] or the intein fusion protein method, which do not require
a recombinant enzyme [21]. Moreover, we have recently succeeded
in the synthesizing NPGL through microwave-assisted solid-phase
peptide synthesis (SPPS), using the rink-amide resin [6]. NPGM con-
taining a C-terminal amidation will be synthesized in a similar way
in the near future. Currently, we are usingmicrowave-assisted SPPS
to prepare NPGM with good yield and purity.
We expected that NPGM was a secretory small protein because
of the presence of a putative signal sequence at the N-terminal
region of the protein precursor. In this study, we showed that
NPGM is indeed a secretory protein using CHO cells. The
N-terminus of the secreted NPGM is located just after the signal
peptide, as expected. The C-terminus of the secreted NPGM was
not amidated and contained an additional region of several amino
acids. We believed that the C-terminus was uncleaved because of
the nature of the secretory pathway in CHO cells. In fact, it has
been reported that prorenin, which contains a Lys–Arg site, was
also uncleaved in CHO cells, which have only the constitutive
secretory pathway, while it was converted to active renin in AtT-
20 cells, which have regulated secretory pathways [22]. Although
we chose CHO cells for their manageability and productivity, it
would be better to use endocrine cells such as AtT-20 cells, to
demonstrate the presence of the mature form of a C-terminal ami-
dated NPGM. Besides carrying out in vitro analyses, we would like
to show the endogenous mature form in the rat hypothalamus.
We are currently working to achieve this goal, using the specific
antibodies against NPGM that we raised in this study.
Judging from the conservation of the Cys residues between
NPGL and NPGM, we speculated that Cys1 and Cys3 of mammalian
NPGM are also involved in the formation of a disulfide bond
(Fig. 1). However, rat NPGM expressed in E. coli was bridged
between Cys1 and Cys2. The location of the disulfide bond did not
change when NPGM was reduced and bridged again using a glu-
tathione or DMSO/HCl. NPGM secreted from mammalian CHO cells
displayed the same bridge between Cys1 and Cys2. These results
confirmed that Cys1 and Cys2 are involved in a disulfide bond while
Cys3 remains free. It has been shown that many proteins contain a
free Cys residue. Human interleukin-2 has a free Cys residue that is
not necessary for the interaction with the receptor [23]. Similarly
the free Cys residues in herpes simplex virus type 1 glycoprotein
D [24] and in human granulocyte colony stimulating factor [25],
are not necessary for their activities and are located in inaccessible
positions, in the transmembrane region and in the interior of the
protein, respectively. It has been reported that elimination of afree Cys residue in human interferon-b and in Drosophila acetyl-
cholinesterase improves their stability [26,27]. Furthermore, it is
known that disulfide isomerization driven by a free Cys residue
is required to activate phage endolysin [28,29]. As the function of
NPGM is unknown at the present time, the contribution of the
disulfide bond and of the free Cys residue to its activity are still
obscure. It is possible that NPGM forms a dimer, although we think
that this is unlikely. The dimerization product of NPGM has not
been observed.
In conclusion, in this study we produced recombinant rat NPGM
in E. coli and in mammalian cells and showed that it is a small
secretory protein, with two Cys residues, Cys1 and Cys2, involved
in the formation of a disulfide bond and a third free Cys. In the
future, we will undertake studies to elucidate the physiological
function of NPGM and to investigate the importance of the disul-
fide bond, of the free Cys residue, and of the C-terminal amidation
for protein activity.
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